false
OasisLMS
Login
Catalog
Office-Based Buprenorphine Treatment of Opioid Use ...
Module 1 - View Lecture
Module 1 - View Lecture
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This course introduces medication-assisted treatment for opioid use disorder, with a primary focus on buprenorphine and establishing office-based care. It reviews diagnosis and patient assessment, treatment goals, medication options, clinical management, counseling, confidentiality, special populations, and relevant regulations.<br /><br />The speakers emphasize that opioid use disorder is a chronic condition and that detoxification alone is inadequate: relapse is common, and reduced tolerance increases overdose risk. Effective care combines medication with behavioral support, mutual-help groups, and recovery-oriented activities. Methadone, buprenorphine, and extended-release naltrexone each have benefits and limitations; treatment choice should reflect the patient’s health, preferences, circumstances, and goals. Ongoing medication can reduce illicit opioid use, overdose risk, and other harms while supporting improved functioning.<br /><br />A case study illustrates shared decision-making, including discussion of buprenorphine maintenance and withdrawal followed by injectable naltrexone. The course also describes the shift from prescription opioids and heroin toward fentanyl, rising overdose deaths, and risks associated with xylazine. Recent policy changes eliminated the federal buprenorphine waiver and patient caps, while new training requirements and proposed telehealth rules are discussed. Newer formulations and overdose-reversal medications are also reviewed.
Keywords
opioid use disorder
medication-assisted treatment
buprenorphine
office-based care
methadone
extended-release naltrexone
counseling
overdose risk
fentanyl
×
Please select your language
1
English